Suppr超能文献

对健康男性志愿者静脉推注或恒速静脉输注依托那龙的浓度-效应关系。

Concentration-effect relationships of eltanolone given as a bolus dose or constant rate intravenous infusion to healthy male volunteers.

作者信息

Wessén A, Parivar K, Widman M, Nilsson A, Hartvig P

机构信息

Department of Anesthesiology, University Hospital, Uppsala, Sweden.

出版信息

Anesthesiology. 1996 Jun;84(6):1317-26. doi: 10.1097/00000542-199606000-00007.

Abstract

BACKGROUND

The primary purpose of this study was to evaluate concentration-effect relationships of the new steroid anesthetic eltanolone during recovery from a bolus dose and constant rate intravenous infusion in healthy male volunteers.

METHODS

Ten subjects received a bolus dose of 0.75 mg/kg eltanolone over 20 s. A 2-h constant rate intravenous infusion of eltanolone was given to five subjects at a rate of 2 mg.kg-1.h-1 and to another five subjects at a rate of 3.5 mg.kg-1.h-1. Recovery performance was assessed as the time required to reach different end-points and by means of three different psychomotor tests.

RESULTS

A low interindividual variability was found in the serum concentration of eltanolone at the pharmacodynamic end-points during recovery. The Cp50 value for "eye opening" was 382 micrograms/L (95% confidence interval, 285-489) after a bolus dose corresponding to a median time of 16 min (range 8-25). After eltanolone infusion, the Cp50 value for "eye opening" was 507 micrograms/L (95% confidence interval, 425-605) and the corresponding median time was 21 min (range 8-25) in the low-dose group and 49 min (range 31-66) in the high-dose group. The Cp50 values at the same effect end-points in the bolus group were less than those in the infusion groups, probably because of insufficient equilibration time between serum and the effect compartment.

CONCLUSIONS

Recovery characteristics of eltanolone were predictable because of a relatively low interindividual variability in serum concentrations but with a slow blood:effect compartment equilibration.

摘要

背景

本研究的主要目的是评估新型甾体麻醉药依他诺龙在健康男性志愿者单次静脉推注和持续静脉输注后恢复过程中的浓度-效应关系。

方法

10名受试者在20秒内接受0.75mg/kg依他诺龙的单次静脉推注。5名受试者以2mg·kg⁻¹·h⁻¹的速率接受依他诺龙2小时的持续静脉输注,另外5名受试者以3.5mg·kg⁻¹·h⁻¹的速率接受输注。恢复表现通过达到不同终点所需的时间以及三种不同的精神运动测试来评估。

结果

恢复过程中,在药效学终点时依他诺龙的血清浓度个体间变异性较低。单次静脉推注后,“睁眼”的半数有效浓度(Cp50)值为382μg/L(95%置信区间,285 - 489)对应中位时间为16分钟(范围8 - 25分钟)。依他诺龙输注后,低剂量组“睁眼”的Cp50值为507μg/L(95%置信区间,425 - 605),相应中位时间为21分钟(范围8 - 25分钟),高剂量组为49分钟(范围31 - 66分钟)。单次静脉推注组相同效应终点的Cp50值低于输注组,可能是因为血清与效应室之间的平衡时间不足。

结论

依他诺龙的恢复特征具有可预测性,因为血清浓度个体间变异性相对较低,但血-效应室平衡缓慢。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验